TRANSVAC: new vaccines faster

Welcome to TRANSVAC, a collaborative infrastructure project funded under the European Commission’s (EC) 7th Framework Programme (FP7). The project is the joint effort of leading European groups in the field of vaccine development, and is coordinated by the European Vaccine Initiative (EVI). TRANSVAC was designed in order to enhance European research and training and foster the seamless implementation of a permanent research infrastructure for early vaccine development in Europe.

In order to reach its ambitious goal, TRANSVAC carries out activities at various levels. On this website you can find out about how to benefit from TRANSVAC’s portfolio of activities, learn how to apply for access to the TRANSVAC’s high-quality Infrastructure Free Services and Paid Services, how to participate in the free Workshops on Animal Models or in the free Modular Course on Concepts on Vaccine Development. Finally, TRANSVAC looks to the future and is exploring the implementation of a road map towards a sustainable European vaccine development platform beyond TRANSVAC. This is done by the European Vaccine Development Stakeholder Working Groups.

News

15 April 2014

EVI commemorates World Malaria Day

In 2008 the World Health Organization designated 25 April as World Malaria Day, since when it has been commemorated by EVI in order to bring attention to this devastating disease that causes enormous loss of young lives, particularly in sub-Saharan Africa.

15 April 2014

#EDCTP2 proposal approved by the European Parliament

With an overwhelming majority the European Parliament approved the #EDCTP2 proposal.

EVI extends hearty congratulations to Charles Mgone and his team.

02 April 2014

TRANSVAC Roadmap now available

EVI is proud to announce that the TRANSVAC consortium has drafted a roadmap entitled Towards a European Vaccine R&D Infrastructure: A Roadmap for Success